Similar articles

• Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the preoperative aspirin and postoperative antiplatelets in coronary artery bypass grafting surgery.

  Refiker M. Refiker M. Am Heart J. 2011 May;161(5):e25; author reply e27. doi: 10.1016/j.ahj.2011.02.026. Epub 2011 Apr 7. Am Heart J. 2011. PMID: 21570501 No abstract available.
• Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  Stein PD, Schünemann HJ, Dalen JE, Gutterman D. Stein PD, et al. Chest. 2004 Sep;126(3 Suppl):600S-608S. doi: 10.1378/chest.126.3_suppl.600S. Chest. 2004. PMID: 15383486 Review.
• Efficacy and safety of anticoagulant therapy started pre-operatively in preventing coronary vein graft occlusion.

  Yli-Mäyry S, Huikuri HV, Korhonen UR, Airaksinen KE, Ikäheimo MJ, Linnaluoto MK, Takkunen JT. Yli-Mäyry S, et al. Eur Heart J. 1992 Sep;13(9):1259-64. doi: 10.1093/oxfordjournals.eurheartj.a060346. Eur Heart J. 1992. PMID: 1396838 Clinical Trial.
• Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion.

  Chong BH. Chong BH. Aust N Z J Med. 1992 Dec;22(6):645-6. doi: 10.1111/j.1445-5994.1992.tb04863.x. Aust N Z J Med. 1992. PMID: 1489286 No abstract available.
• Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: the basis of their use, data from animal studies, clinical trial data, and current recommendations.

  Chesebro JH, Fuster V. Chesebro JH, et al. Cardiology. 1986;73(4-5):292-305. doi: 10.1159/000174022. Cardiology. 1986. PMID: 2944585 Review.